Collaborative and Seamless Care in Oncology : a Study in Primary Care to Measure and Reinforce Safety and Adherence to Oral Cancer Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- Enrollment
- 43
- Locations
- 1
- Primary Endpoint
- Change in Medication adherence
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.
Detailed Description
80 patients will be included in swiss-romande hospitals and private oncologists and followed by thirty study pharmacies. Each refusal and drop-out will be documented. Follow-up duration is 48 weeks, with a motivational interviewing at least every three months. Patient adherence will be assessed electronically by MEMS (Medication Event Monitoring System).
Investigators
Marie Schneider
Dr
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Eligibility Criteria
Inclusion Criteria
- •18 years and older
- •Treated for a cancer with oral medication (letrozol, exemestan,imatinib, sunitinib, nilotinib, everolimus, deferasirox)
- •French speaking
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change in Medication adherence
Time Frame: 3 months, 6 months, 9 months, 12 months
MEMS data, completed by informations given in motivational interviewing
Secondary Outcomes
- Program implementation(1 year)
- Effect of Adverse Drug Reaction (ADR) on medication adherence(1 year)
- Oncologists, nurses, pharmacists and patients satisfaction(1 year)
- Change in Adverse Drug Reaction (ADR)(3 months, 6 months, 9 months, 12 months)